Reciprocal Influences of HIV and Cannabinoids on the Brain and Cognitive Function.

Reciprocal Influences of HIV and Cannabinoids on the Brain and Cognitive Function.
复制标题

艾滋病毒和大麻素对大脑和认知功能的相互影响。

DOI:
10.1007/s11481-020-09921-y
复制
发表时间:
2020-12
期刊:
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
影响因子:
--
通讯作者:
Chang L
Chang L
中科院分区:
其他
文献类型:
--
作者:
Towe SL;Meade CS;Cloak CC;Bell RP;Baptiste J;Chang L

文献摘要

参考文献

相似文献

在全球范围内,大麻是最常用的非法药物,在艾滋病毒携带者中使用率高得不成比例。尽管在艾滋病毒护理方面取得了进展,但近一半的艾滋病毒携带者继续经历神经认知缺陷或损害,这可能对他们的日常功能产生负面影响。长期使用大麻可能在这些损害的发展或加重中发挥作用。在这里,我们提供了一篇综述,总结了现有的研究,详细说明了大麻使用与艾滋病毒神经发病相关的影响。我们在临床前和成人人类文献中检查了艾滋病毒感染和大麻使用对神经艾滋病毒可能的相加或协同作用的证据,包括体外研究、动物模型、临床神经成像研究,以及研究大麻的认知影响。我们讨论了现有研究的局限性,包括与人类受试者的临床研究有关的方法学挑战。我们找出该领域的差距,并提出关键的研究问题,以促进我们对大麻使用如何影响神经艾滋病毒的理解。
Globally, cannabis is the most commonly used illicitdrug, with disproportionately high use among persons with HIV. Despite advances in HIV care, nearly half of persons with HIV continue to experience neurocognitive deficits or impairments that may have negative impacts on their daily function. Chronic cannabis use may play a role in the development or exacerbation of these impairments. Here we present a review summarizing existing research detailing the effect of cannabis use associated with the neuropathogenesis of HIV. We examine evidence for possible additive or synergistic effects of HIV infection and cannabis use on neuroHIV in both the preclinical and adult human literatures, including in vitro studies, animal models, clinical neuroimaging research, and studies examining the cognitive effects of cannabis. We discuss the limitations of existing research, including methodological challenges involved with clinical research with human subjects. We identify gaps in the field and propose critical research questions to advance our understanding of how cannabis use affects neuroHIV.
DOI: 10.1097/adm.0b013e31820c23fa
发表时间: 2011-03
影响因子: 5.5
作者:
Crean RD;Crane NA;Mason BJ
通讯作者: Mason BJ
DOI: 10.1016/j.neuropharm.2017.06.017
发表时间: 2017-09-15
期刊: Neuropharmacology
影响因子: 4.7
作者:
Araque A;Castillo PE;Manzoni OJ;Tonini R
通讯作者: Tonini R
DOI: 10.1097/qai.0b013e318229ba41
发表时间: 2011-10-01
期刊: Journal of acquired immune deficiency syndromes (1999)
影响因子: --
作者:
Byrd DA;Fellows RP;Morgello S;Franklin D;Heaton RK;Deutsch R;Atkinson JH;Clifford DB;Collier AC;Marra CM;Gelman B;McCutchan JA;Duarte NA;Simpson DM;McArthur J;Grant I;CHARTER Group
通讯作者: CHARTER Group
DOI: 10.1016/j.dcn.2015.10.004
发表时间: 2015-12
影响因子: 4.7
作者:
Becker MP;Collins PF;Lim KO;Muetzel RL;Luciana M
通讯作者: Luciana M
DOI: 10.1111/bph.12478
发表时间: 2014-01-01
影响因子: 7.3
作者:
Avraham, Hava Karsenty;Jiang, Shuxian;Avraham, Shalom
通讯作者: Avraham, Shalom